Enter your login e-mail to the account
Search
Search parameters
Search results
- Intrathecal synthesis of specific antiviral antibodies in relapsing-remitting and primary chronic progressive courses of multiple sclerosis
doc. MUDr. Pavel Štourač, Ph.D., MUDr. Jana Bednářová, Ph.D.
(5/2009, Main topic ) - Experience with shortened ocrelizumab infusion – ENSEMBLE PLUS study
doc. MUDr. Yvonne Benešová, Ph.D.
(1/2022, Review articles ) - Central nervous system vasculitis
MUDr. Aleš Tomek, Ph.D., FESO
(6/2015, Main topic ) - Anti CD20 multiple sclerosis therapy
Doc. MUDr. Pavel Štourač, Ph.D.
(1/2018, Pharmacotherapy ) - The use of monoclonal antibodies in neurology
prof. MUDr. Egon Kurča, PhD., MUDr. Mária Cuninková
(6/2011, Main topic ) - Current role of evoked potentials in multiple sclerosis diagnostics and monitoring
MUDr. Václav Boček, Ph.D.
(2/2021, Review articles ) - Errors and mistakes in diagnosing multiple sclerosis
MUDr. Jiří Piťha
(3/2015, Review articles ) - Ocrelizumab – pharmacoloical profile
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(5/2018, Pharmacotherapy ) - Importance of early diagnosis and treatment in the life perspective of patients with multiple sclerosis
doc. MUDr. Jan Mareš, Ph.D.
(5/2012, Review articles ) - Monoklonální protilátky v léčbě roztroušené sklerózy
MUDr. Marek Peterka , MUDr. Zdeněk Kasl, Ph.D.
(2/2018, Pharmacotherapy ) - Long-term data of multiple sclerosis treatment with ocrelizumab – eficacy, safety and clinical experience
MUDr. Mgr. Matouš Rous, MUDr. Zuzana Rous, Ph.D.
(6/2021, Review articles ) - Treatment persistence to ocrelizumab and local experience
MUDr. Simona Halúsková, prof. MUDr. Martin Vališ, Ph.D., FEAN
(3/2021, Review articles ) - B cells as a target in the treatment of multiple sclerosis
MUDr. Luděk Hochmuth
(3/2017, Review articles ) - Late Lyme neuroborreliosis or post-Lyme borreliosis syndrome? A case report
MUDr. Ladislav Gurčík, PhD.
(6/2010, Case reports ) - Longterm safety of Ocrelizumab in Multiple Sclerosis treatment
MUDr. Marek Peterka , MUDr. Pavel Potužník
(4/2020, Review articles ) - Primary progressive multiple sclerosis – diagnosis, clinical aspects and treatment
MUDr. Ladislav Gurčík, PhD.
(5/2011, Review articles ) - Cesta ke spolehlivé diagnostice roztroušené sklerózy
MUDr. Radomír Taláb, CSc.
(4/2008, Main topic ) - Léčba progresivní roztroušené sklerózy
MUDr. Ivana Kovářová
(4/2008, Main topic ) - Ocrelizumab v léčbě roztroušené sklerózy
Prof. MUDr. Eva Kubala Havrdová, CSc.
(4/2017, Pharmacotherapy ) - B‑ lymphocyte‑ targeted MS therapy: from theory to a decade of ocrelizumab in practice
MUDr. Dominika Šťastná, Ph.D., MUDr. Jana Seňavová, prof. MUDr. Dana Horáková, Ph.D.
(2/2024, Review articles ) - The influence on long-term progression of multiple sclerosis – brighter days ahead?
MUDr. Dominika Šťastná, doc. MUDr. Dana Horáková, Ph.D.
(1/2021, Review articles ) - Ocrelizumab and novel therapeutic goals in multiple sclerosis
MUDr. Radek Ampapa
(2/2020, Review articles )
- HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMOPOIETIC CELL TRANSPLANTATION
MUDr. Ján Gyárfáš
(5/2008, Review articles )
- Chronic cerebrospinal venous insufficiency and its controversial relationship with multiple sclerosis
MUDr. Juraj Maďarič, PhD., MPH, MUDr. Ivan Vulev, PhD., MPH, FCIRSE
(1/2014, Main topic )